Financials
Income statement
Fiscal date | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total reported revenue | 39.3B | 35.9B | 30.7B | 27.6B |
Cost of revenue | 22.3B | 21.1B | 18.1B | 15.9B |
Gross profit | 17.0B | 14.7B | 12.5B | 11.7B |
Operating expense | ||||
Research & development | 267.7M | 303.0M | 319.7M | 309.5M |
Selling general and admin | 377.3M | 334.4M | 307.8M | 294.6M |
Other operating expenses | 2.4B | 2.2B | 1.9B | 1.8B |
Operating income | 10.2B | 8.4B | 6.5B | 5.4B |
Non operating interest income | ||||
Income | 12.2M | 11.2M | 10.9M | 11.6M |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 11.3B | 9.0B | 7.0B | 5.9B |
Tax provision | 3.4B | 2.7B | 2.3B | 2.0B |
Net income | 7.9B | 6.3B | 4.7B | 3.9B |
Basic EPS | — | 342.6 | 255.8 | 211.0 |
Diluted EPS | — | 342.6 | 255.8 | 211.0 |
Basic average shares | — | 18.4M | 18.3M | 18.3M |
Diluted average shares | — | 18.4M | 18.3M | 18.3M |
EBITDA | 10.7B | 8.9B | 7.1B | 6.6B |
Net income from continuing op. | 11.3B | 9.0B | 7.0B | 5.9B |
Minority interests | 0 | -995K | -1.9M | -1.7M |
Preferred stock dividends | 0 | 0 | 0 | 0 |